Interleukin-20 family signaling (Homo sapiens)

From WikiPathways

Revision as of 12:06, 25 July 2016 by Ryanmiller (Talk | contribs)
Jump to: navigation, search
25, 74883, 61, 4, 9cytosolIL22RA2IL22RA1 IL22RA1:IL20RB:IL20,IL24IL22 IL20RB IL22 IL22RA1:IL20RBIL20,IL24IL20 IL22RA1IL24 IL22RA2 IL19 IL20RAIL19 IL24 IL20RB IL10RB IL22RA1 IL24 IL22RA2:IL22IL20RA:IL20RB:IL19,IL20,IL24IL22RA1 IL22RA1 IL20RA IL22IL20RB IL10RBIL22RA1:IL22:IL10RBIL22 IL20 IL22RA1:IL22IL19,IL20,IL24IL20 IL20RA:IL20RBIL20RBIL20RA IL20RB IL20 IL24


Description

The interleukin-20 (IL20) subfamily comprises IL19, IL-20, IL-22, IL-24 and IL-26. They are members of the larger IL-10 family, but have been grouped together based on their usage of common receptor subunits and similarities in their target-cell profiles and biological functions. Members of the IL20 subfamily facilitate the communication between leukocytes and epithelial cells, thereby enhancing innate defence mechanisms and tissue repair processes at epithelial surfaces. Much of the understanding of this group of cytokines is based on IL22, which is the most studied member (Rutz et al. 2014). View original pathway at:Reactome.

Comments

Reactome Converter 
Pathway is converted from Reactome id:

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Braunstein J, Brutsaert S, Olson R, Schindler C.; ''STATs dimerize in the absence of phosphorylation.''; PubMed Europe PMC Scholia
  2. Wang M, Tan Z, Zhang R, Kotenko SV, Liang P.; ''Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2.''; PubMed Europe PMC Scholia
  3. Novak AJ, Grote DM, Ziesmer SC, Rajkumar V, Doyle SE, Ansell SM.; ''A role for IFN-lambda1 in multiple myeloma B cell growth.''; PubMed Europe PMC Scholia
  4. Floss DM, Klöcker T, Schröder J, Lamertz L, Mrotzek S, Strobl B, Hermanns H, Scheller J.; ''Defining the functional binding sites of interleukin 12 receptor β1 and interleukin 23 receptor to Janus kinases.''; PubMed Europe PMC Scholia
  5. Logsdon NJ, Deshpande A, Harris BD, Rajashankar KR, Walter MR.; ''Structural basis for receptor sharing and activation by interleukin-20 receptor-2 (IL-20R2) binding cytokines.''; PubMed Europe PMC Scholia
  6. Donnelly RP, Sheikh F, Dickensheets H, Savan R, Young HA, Walter MR.; ''Interleukin-26: an IL-10-related cytokine produced by Th17 cells.''; PubMed Europe PMC Scholia
  7. Walter MR.; ''The molecular basis of IL-10 function: from receptor structure to the onset of signaling.''; PubMed Europe PMC Scholia
  8. Haan C, Kreis S, Margue C, Behrmann I.; ''Jaks and cytokine receptors--an intimate relationship.''; PubMed Europe PMC Scholia
  9. Tritsaris K, Myren M, Ditlev SB, Hübschmann MV, van der Blom I, Hansen AJ, Olsen UB, Cao R, Zhang J, Jia T, Wahlberg E, Dissing S, Cao Y.; ''IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs.''; PubMed Europe PMC Scholia
  10. Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD, Vazquez N, Pestka S, Donnelly RP, Kotenko SV.; ''Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10).''; PubMed Europe PMC Scholia
  11. Ferrao R, Lupardus PJ.; ''The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK-Receptor Interactions.''; PubMed Europe PMC Scholia
  12. Rutz S, Wang X, Ouyang W.; ''The IL-20 subfamily of cytokines--from host defence to tissue homeostasis.''; PubMed Europe PMC Scholia
  13. Ferrao R, Wallweber HJ, Ho H, Tam C, Franke Y, Quinn J, Lupardus PJ.; ''The Structural Basis for Class II Cytokine Receptor Recognition by JAK1.''; PubMed Europe PMC Scholia
  14. Xu W, Presnell SR, Parrish-Novak J, Kindsvogel W, Jaspers S, Chen Z, Dillon SR, Gao Z, Gilbert T, Madden K, Schlutsmeyer S, Yao L, Whitmore TE, Chandrasekher Y, Grant FJ, Maurer M, Jelinek L, Storey H, Brender T, Hammond A, Topouzis S, Clegg CH, Foster DC.; ''A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist.''; PubMed Europe PMC Scholia
  15. Lee SJ, Lee EJ, Kim SK, Jeong P, Cho YH, Yun SJ, Kim S, Kim GY, Choi YH, Cha EJ, Kim WJ, Moon SK.; ''Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.''; PubMed Europe PMC Scholia
  16. Shuai K, Horvath CM, Huang LH, Qureshi SA, Cowburn D, Darnell JE.; ''Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions.''; PubMed Europe PMC Scholia
  17. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM.; ''IL-28, IL-29 and their class II cytokine receptor IL-28R.''; PubMed Europe PMC Scholia
  18. Sheikh F, Baurin VV, Lewis-Antes A, Shah NK, Smirnov SV, Anantha S, Dickensheets H, Dumoutier L, Renauld JC, Zdanov A, Donnelly RP, Kotenko SV.; ''Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2.''; PubMed Europe PMC Scholia
  19. Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD.; ''Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.''; PubMed Europe PMC Scholia
  20. Jain S, Gabunia K, Kelemen SE, Panetti TS, Autieri MV.; ''The anti-inflammatory cytokine interleukin 19 is expressed by and angiogenic for human endothelial cells.''; PubMed Europe PMC Scholia
  21. Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, Storey H, Yao L, Liu H, Barahmand-pour F, Sivakumar P, Chan C, Birks C, Foster D, Clegg CH, Wietzke-Braun P, Mihm S, Klucher KM.; ''Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes.''; PubMed Europe PMC Scholia
  22. Wehinger J, Gouilleux F, Groner B, Finke J, Mertelsmann R, Weber-Nordt RM.; ''IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes.''; PubMed Europe PMC Scholia
  23. Pletnev S, Magracheva E, Kozlov S, Tobin G, Kotenko SV, Wlodawer A, Zdanov A.; ''Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20.''; PubMed Europe PMC Scholia
  24. Hör S, Pirzer H, Dumoutier L, Bauer F, Wittmann S, Sticht H, Renauld JC, de Waal Malefyt R, Fickenscher H.; ''The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains.''; PubMed Europe PMC Scholia
  25. Yoon SI, Jones BC, Logsdon NJ, Harris BD, Deshpande A, Radaeva S, Halloran BA, Gao B, Walter MR.; ''Structure and mechanism of receptor sharing by the IL-10R2 common chain.''; PubMed Europe PMC Scholia
  26. Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, Duan S, Eiwegger T, Eljaszewicz A, Ferstl R, Frei R, Garbani M, Globinska A, Hess L, Huitema C, Kubo T, Komlosi Z, Konieczna P, Kovacs N, Kucuksezer UC, Meyer N, Morita H, Olzhausen J, O'Mahony L, Pezer M, Prati M, Rebane A, Rhyner C, Rinaldi A, Sokolowska M, Stanic B, Sugita K, Treis A, van de Veen W, Wanke K, Wawrzyniak M, Wawrzyniak P, Wirz OF, Zakzuk JS, Akdis CA.; ''Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases.''; PubMed Europe PMC Scholia
  27. Gad HH, Dellgren C, Hamming OJ, Vends S, Paludan SR, Hartmann R.; ''Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family.''; PubMed Europe PMC Scholia
  28. Tian Y, Sommerville LJ, Cuneo A, Kelemen SE, Autieri MV.; ''Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia.''; PubMed Europe PMC Scholia
  29. Sestito R, Madonna S, Scarponi C, Cianfarani F, Failla CM, Cavani A, Girolomoni G, Albanesi C.; ''STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation.''; PubMed Europe PMC Scholia
  30. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, West J, Brandt C, Jelinek L, Madden K, McKernan PA, Foster DC, Jaspers S, Chandrasekher YA.; ''Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions.''; PubMed Europe PMC Scholia
  31. Dumoutier L, Lejeune D, Colau D, Renauld JC.; ''Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22.''; PubMed Europe PMC Scholia
  32. Vignali DA, Kuchroo VK.; ''IL-12 family cytokines: immunological playmakers.''; PubMed Europe PMC Scholia
  33. Jones BC, Logsdon NJ, Walter MR.; ''Structure of IL-22 bound to its high-affinity IL-22R1 chain.''; PubMed Europe PMC Scholia
  34. Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL.; ''Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R.''; PubMed Europe PMC Scholia
  35. Dumoutier L, Tounsi A, Michiels T, Sommereyns C, Kotenko SV, Renauld JC.; ''Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.''; PubMed Europe PMC Scholia
  36. Yoon SI, Logsdon NJ, Sheikh F, Donnelly RP, Walter MR.; ''Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex.''; PubMed Europe PMC Scholia
  37. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T.; ''Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway.''; PubMed Europe PMC Scholia
  38. Sainz-Perez A, Gary-Gouy H, Gaudin F, Maarof G, Marfaing-Koka A, de Revel T, Dalloul A.; ''IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression.''; PubMed Europe PMC Scholia
  39. Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP, Pestka S.; ''Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity.''; PubMed Europe PMC Scholia
  40. You W, Tang Q, Zhang C, Wu J, Gu C, Wu Z, Li X.; ''IL-26 promotes the proliferation and survival of human gastric cancer cells by regulating the balance of STAT1 and STAT3 activation.''; PubMed Europe PMC Scholia
  41. Liu L, McBride KM, Reich NC.; ''STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3.''; PubMed Europe PMC Scholia
  42. Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC.; ''Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.''; PubMed Europe PMC Scholia
  43. Andoh A, Shioya M, Nishida A, Bamba S, Tsujikawa T, Kim-Mitsuyama S, Fujiyama Y.; ''Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease.''; PubMed Europe PMC Scholia
  44. Meng S, Gui Q, Xu Q, Lu K, Jiao X, Fan J, Ge B, Ke Y, Zhang S, Wu J, Wang C.; ''Association of Shp2 with phosphorylated IL-22R1 is required for interleukin-22-induced MAP kinase activation.''; PubMed Europe PMC Scholia
  45. Li J, Tomkinson KN, Tan XY, Wu P, Yan G, Spaulding V, Deng B, Annis-Freeman B, Heveron K, Zollner R, De Zutter G, Wright JF, Crawford TK, Liu W, Jacobs KA, Wolfman NM, Ling V, Pittman DD, Veldman GM, Fouser LA.; ''Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2.''; PubMed Europe PMC Scholia
  46. Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T.; ''Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family.''; PubMed Europe PMC Scholia
  47. Finbloom DS, Winestock KD.; ''IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes.''; PubMed Europe PMC Scholia
  48. Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T, Carollo S, Eagan M, Foster D, Haldeman BA, Hammond A, Haugen H, Jelinek L, Kelly JD, Madden K, Maurer MF, Parrish-Novak J, Prunkard D, Sexson S, Sprecher C, Waggie K, West J, Whitmore TE, Yao L, Kuechle MK, Dale BA, Chandrasekher YA.; ''Interleukin 20: discovery, receptor identification, and role in epidermal function.''; PubMed Europe PMC Scholia
  49. Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T.; ''New microRNAs from mouse and human.''; PubMed Europe PMC Scholia
  50. Naeger LK, McKinney J, Salvekar A, Hoey T.; ''Identification of a STAT4 binding site in the interleukin-12 receptor required for signaling.''; PubMed Europe PMC Scholia
  51. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, O'Brien TR.; ''A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.''; PubMed Europe PMC Scholia
  52. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC.; ''Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types.''; PubMed Europe PMC Scholia
  53. Vandenbroeck K, Alvarez J, Swaminathan B, Alloza I, Matesanz F, Urcelay E, Comabella M, Alcina A, Fedetz M, Ortiz MA, Izquierdo G, Fernandez O, Rodriguez-Ezpeleta N, Matute C, Caillier S, Arroyo R, Montalban X, Oksenberg JR, Antigüedad A, Aransay A.; ''A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114997view16:53, 25 January 2021ReactomeTeamReactome version 75
113441view11:51, 2 November 2020ReactomeTeamReactome version 74
112642view16:02, 9 October 2020ReactomeTeamReactome version 73
101557view11:43, 1 November 2018ReactomeTeamreactome version 66
101093view21:25, 31 October 2018ReactomeTeamreactome version 65
100622view20:00, 31 October 2018ReactomeTeamreactome version 64
100173view16:44, 31 October 2018ReactomeTeamreactome version 63
99723view15:11, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
99297view12:46, 31 October 2018ReactomeTeamreactome version 62
94490view08:53, 14 September 2017Mkutmonreactome pathway rename
87863view12:06, 25 July 2016RyanmillerOntology Term : 'signaling pathway' added !
86561view09:21, 11 July 2016ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
IL10RB ProteinQ08334 (Uniprot-TrEMBL)
IL10RBProteinQ08334 (Uniprot-TrEMBL)
IL19 ProteinQ9UHD0 (Uniprot-TrEMBL)
IL19,IL20,IL24ComplexR-HSA-448716 (Reactome)
IL20 ProteinQ9NYY1 (Uniprot-TrEMBL)
IL20,IL24ComplexR-HSA-448734 (Reactome)
IL20RA ProteinQ9UHF4 (Uniprot-TrEMBL)
IL20RA:IL20RB:IL19,IL20,IL24ComplexR-HSA-448743 (Reactome)
IL20RA:IL20RBComplexR-HSA-448724 (Reactome)
IL20RAProteinQ9UHF4 (Uniprot-TrEMBL)
IL20RB ProteinQ6UXL0 (Uniprot-TrEMBL)
IL20RBProteinQ6UXL0 (Uniprot-TrEMBL)
IL22 ProteinQ9GZX6 (Uniprot-TrEMBL)
IL22ProteinQ9GZX6 (Uniprot-TrEMBL)
IL22RA1 ProteinQ8N6P7 (Uniprot-TrEMBL)
IL22RA1:IL20RB:IL20,IL24ComplexR-HSA-448735 (Reactome)
IL22RA1:IL20RBComplexR-HSA-448727 (Reactome)
IL22RA1:IL22:IL10RBComplexR-HSA-8854697 (Reactome)
IL22RA1:IL22ComplexR-HSA-448411 (Reactome)
IL22RA1ProteinQ8N6P7 (Uniprot-TrEMBL)
IL22RA2 ProteinQ969J5 (Uniprot-TrEMBL)
IL22RA2:IL22ComplexR-HSA-448738 (Reactome)
IL22RA2ProteinQ969J5 (Uniprot-TrEMBL)
IL24 ProteinQ13007 (Uniprot-TrEMBL)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
IL10RBR-HSA-8854645 (Reactome)
IL19,IL20,IL24R-HSA-448728 (Reactome)
IL20,IL24R-HSA-448708 (Reactome)
IL20RA:IL20RB:IL19,IL20,IL24ArrowR-HSA-448728 (Reactome)
IL20RA:IL20RBArrowR-HSA-448744 (Reactome)
IL20RA:IL20RBR-HSA-448728 (Reactome)
IL20RAR-HSA-448744 (Reactome)
IL20RBR-HSA-448744 (Reactome)
IL22R-HSA-448480 (Reactome)
IL22R-HSA-448741 (Reactome)
IL22RA1:IL20RB:IL20,IL24ArrowR-HSA-448708 (Reactome)
IL22RA1:IL20RBR-HSA-448708 (Reactome)
IL22RA1:IL22:IL10RBArrowR-HSA-8854645 (Reactome)
IL22RA1:IL22ArrowR-HSA-448480 (Reactome)
IL22RA1:IL22R-HSA-8854645 (Reactome)
IL22RA1R-HSA-448480 (Reactome)
IL22RA2:IL22ArrowR-HSA-448741 (Reactome)
IL22RA2:IL22TBarR-HSA-448480 (Reactome)
IL22RA2R-HSA-448741 (Reactome)
R-HSA-448480 (Reactome) The Interleukin-22 receptor is a heterodimer of Interleukin-22 receptor subunit alpha-1 (IL22RA1) and Interleukin-10 receptor subunit beta (IL10RB), a component of the receptors for IL10, IL22, IL26, IL28, and IFNL1. Temporal models suggest that the first event in IL22 receptor formation is binding of Interleukin-22 (IL22) to IL22RA (Li et al. 2004).
R-HSA-448708 (Reactome) IL20 and IL24 can activate a heterodimer of IL22RA and IL20RB (Dumoutier et al. 2001, Parrish-Novak et al. 2002). As it is not clear whether the dimeric receptor can form in the absence of ligand, formation of the receptor dimer is represented here as an uncertain event.
R-HSA-448728 (Reactome) The dimer of Interleukin 20 receptor A (IL20RA) and Interleukin 20 receptor B (IL20RB) is a receptor for Interleukin-19 (IL19), IL20 and IL24 (Parrish-Novak et al. 2002, Logsdon et al. 2012, Rutz et al. 2014). As it is not clear whether the dimeric receptor can form in the absence of ligand, formation of the receptor dimer is represented here as an uncertain event.
R-HSA-448741 (Reactome) Interleukin-22 receptor subunit alpha-2 (IL22RA2), also known as Interleukin-22 binding protein (IL22BP), is a soluble receptor that binds Interleukin-22 (IL22) within the extracellular region, preventing IL22 from binding to the functional membrane-associated IL22 receptor (Xu et al. 2001). This may play a regulatory role in inflammation.
R-HSA-448744 (Reactome) Interleukin 20 receptor A (IL20RA) and Interleukin 20 receptor B (IL20RB) form a receptor for Interleukin-19 (IL19), IL20 and IL24. IL20 and IL24 can also activate a heterodimer of IL22RA:IL20RB (Blumberg et al. 2001, Parrish-Novak et al. 2002, Logsdon et al. 2012, Rutz et al. 2014). As it is not clear whether the dimeric receptor can form in the absence of ligand, formation of the receptor dimer is represented here as an uncertain event.
R-HSA-8854645 (Reactome) Temporal models suggest that binding of Interleukin-22 (IL22) to Interleukin-22 receptor subunit alpha-1 (IL22RA1) creates a surface that is bound by the extracellular region of Interleukin-10 receptor beta chain (IL10RB) (Li et al. 2004).
Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP3817"
Personal tools